Markers released top-line results today after previously reporting the trial succeeded.
Read More

Markers released top-line results today after previously reporting the trial succeeded.
Read More
The vaccine reportedly thwarted the cancer's return and spread.
Read More
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Read More